Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?”

Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?”

Anemia is a common complication of chronic kidney disease (CKD). The prevalence of anemia in CKD strongly increases as the estimated Glomerular Filtration Rate (eGFR) decreases. The pathophysiology of anemia in CKD is complex. The main causes are erythropoietin (EPO) deficiency and functional iron d...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppina Crugliano, Raffaele Serra, Nicola Ielapi, Yuri Battaglia, Giuseppe Coppolino, Davide Bolignano, Umberto Marcello Bracale, Antonio Pisani, Teresa Faga, Ashour Michael, Michele Provenzano, Michele Andreucci
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
chronic kidney disease
anemia
erythropoietin
treatment
renal disease
renal failure
Biology (General)
QH301-705.5
Chemistry
QD1-999
Online Access:https://doaj.org/article/9a55450d837e456f908ac29ee726b058
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/9a55450d837e456f908ac29ee726b058

Similar Items